302 related articles for article (PubMed ID: 22086978)
1. Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia.
Jacobs VL; Landry RP; Liu Y; Romero-Sandoval EA; De Leo JA
Neuro Oncol; 2012 Feb; 14(2):119-31. PubMed ID: 22086978
[TBL] [Abstract][Full Text] [Related]
2. Propentofylline targets TROY, a novel microglial signaling pathway.
Jacobs VL; Liu Y; De Leo JA
PLoS One; 2012; 7(5):e37955. PubMed ID: 22649568
[TBL] [Abstract][Full Text] [Related]
3. Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
Dhruv HD; Roos A; Tomboc PJ; Tuncali S; Chavez A; Mathews I; Berens ME; Loftus JC; Tran NL
J Neurooncol; 2016 Feb; 126(3):397-404. PubMed ID: 26559543
[TBL] [Abstract][Full Text] [Related]
4. Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages.
Landry RP; Jacobs VL; Romero-Sandoval EA; DeLeo JA
Exp Neurol; 2012 Apr; 234(2):340-50. PubMed ID: 22119425
[TBL] [Abstract][Full Text] [Related]
5. Exploiting Microglial Functions for the Treatment of Glioblastoma.
Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
[TBL] [Abstract][Full Text] [Related]
6. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
[TBL] [Abstract][Full Text] [Related]
7. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between microglia and patient-derived glioblastoma cells inhibit invasion in a three-dimensional gelatin hydrogel model.
Chen JE; Lumibao J; Leary S; Sarkaria JN; Steelman AJ; Gaskins HR; Harley BAC
J Neuroinflammation; 2020 Nov; 17(1):346. PubMed ID: 33208156
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth.
Rivera-Ramos A; Cruz-Hernández L; Talaverón R; Sánchez-Montero MT; García-Revilla J; Mulero-Acevedo M; Deierborg T; Venero JL; Sarmiento Soto M
Cancer Lett; 2024 Jun; 591():216879. PubMed ID: 38636895
[TBL] [Abstract][Full Text] [Related]
10. CXCR4-STAT3 Axis Plays a Role in Tumor Cell Infiltration in an Orthotopic Mouse Glioblastoma Model.
Han JH; Yoon JS; Chang DY; Cho KG; Lim J; Kim SS; Suh-Kim H
Mol Cells; 2020 Jun; 43(6):539-550. PubMed ID: 32597394
[TBL] [Abstract][Full Text] [Related]
11. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma.
Bowman RL; Joyce JA
Immunotherapy; 2014; 6(6):663-6. PubMed ID: 25041027
[No Abstract] [Full Text] [Related]
13. Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors.
Majc B; Habič A; Novak M; Rotter A; Porčnik A; Mlakar J; Župunski V; Pečar Fonović U; Knez D; Zidar N; Gobec S; Kos J; Lah Turnšek T; Pišlar A; Breznik B
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163706
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
15. FTY720 Exerts Anti-Glioma Effects by Regulating the Glioma Microenvironment Through Increased CXCR4 Internalization by Glioma-Associated Microglia.
Guo XD; Ji J; Xue TF; Sun YQ; Guo RB; Cheng H; Sun XL
Front Immunol; 2020; 11():178. PubMed ID: 32194542
[No Abstract] [Full Text] [Related]
16. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
[TBL] [Abstract][Full Text] [Related]
17. The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment.
Sanders S; Herpai DM; Rodriguez A; Huang Y; Chou J; Hsu FC; Seals D; Mott R; Miller LD; Debinski W
Cells; 2021 Sep; 10(9):. PubMed ID: 34572134
[TBL] [Abstract][Full Text] [Related]
18. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma.
Hutter G; Theruvath J; Graef CM; Zhang M; Schoen MK; Manz EM; Bennett ML; Olson A; Azad TD; Sinha R; Chan C; Assad Kahn S; Gholamin S; Wilson C; Grant G; He J; Weissman IL; Mitra SS; Cheshier SH
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):997-1006. PubMed ID: 30602457
[TBL] [Abstract][Full Text] [Related]
19. Properties of activated microglia and pharmacologic interference by propentofylline.
McRae A; Ling EA; Schubert P; Rudolphi K
Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S15-20. PubMed ID: 9769025
[TBL] [Abstract][Full Text] [Related]
20. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA
Amaral RF; Geraldo LHM; Einicker-Lamas M; E Spohr TCLS; Mendes F; Lima FRS
J Neurochem; 2021 Feb; 156(4):499-512. PubMed ID: 32438456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]